Effect of CD133 polymorphisms on the risk of developing liver cirrhosis and hepatocellular carcinoma induced by viral hepatitis

Bibliographic Information
Authors: Hassan M.; Nasr S.M.; Elzallat M.
Journal: Virus Research
Publisher: Elsevier B.V.
Publication Date: April 2022
Volume / Issue: Volume 312
Article No.: 198714
ISSN: 1681702
DOI: 10.1016/j.virusres.2022.198714
Scopus: View on Scopus
PubMed: 35181408
Document Type: Article
Authors and Affiliations
Hassan M., Immunology Department, Theodor Bilharz Research Institute, Warraq El-Hadar, Giza, 12411, Egypt; Nasr S.M., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Elzallat M., Immunology Department, Theodor Bilharz Research Institute, Warraq El-Hadar, Giza, 12411, Egypt
Abstract
Background: CD133 has been postulated to identify cancer stem cells (CSCs) and to play a role in tumorigenesis and cancer progression. The purpose of this study was to explore the impact of CD133 polymorphisms on viral hepatitis-induced liver cirrhosis, as well as hepatocellular carcinoma (HCC) susceptibility and prognosis. Methodology: CD133+ cells were counted and CD133 SNPs (rs3130, rs1029728, rs2240688, and rs2286455) were genotyped in HCV, HCV-liver cirrhosis, HCV-HCC, HBV, HBV-liver cirrhosis, and HBV-HCC patients and disease-free controls. Results: The percentage of CD133+ cells was observed to be significantly higher in HCV- and HBV-associated liver cirrhosis and HCC. Also, the CD133 rs3130 (C > T) TT, rs1029728 (A > G) GG, and rs2240688 (G > T) SNP TT genotypes were associated with a greater risk of liver cirrhosis and HCC development in viral hepatitis patients. Furthermore, in HCV-related HCC, rs3130 TT, rs1029728 GG, or rs2240688 TT genotypes were significantly associated with an increased number and size of focal lesions, but only the rs3130 TT genotype was associated with higher lesion size in HBV-associated HCC. In addition, individuals having rs3130 TT and rs1029728 GG genotypes had a significantly higher percentage of CD133+ cells. However, only HCV-infected individuals, carrying rs2240688 TT genotype, had an elevated level of CD133+ cells. Conclusions: CD133 rs3130, rs1029728, and rs2240688 are genetic factors that can influence the susceptibility to liver cirrhosis and cancer, as well as the prognosis. As a result, CD133+ cells and CD133 polymorphisms might serve as potential predictors of these illnesses, laying the groundwork for the discovery of novel therapeutic targets. © 2022 Elsevier B.V.
Keywords
Cancer stem cell (CSC); CD133; Hepatitis virus; Hepatocellular carcinoma (HCC); Liver cirrhosis; Single nucleotide polymorphism (SNP); Carcinoma, Hepatocellular; Case-Control Studies; Genetic Predisposition to Disease; Genotype; Hepatitis C; Hepatitis, Viral, Human; Humans; Liver Neoplasms; Polymorphism, Single Nucleotide; CD133 antigen; adult; aged; Article; cancer prognosis; cancer susceptibility; female; gene frequency; genotyping; Hepatitis B virus; Hepatitis C virus; human; human cell; liver cell carcinoma; major clinical study; male; risk assessment; single nucleotide polymorphism; case control study; genetic predisposition; genetics; liver tumor; virus hepatitis
Citation Information
Scopus Citations: 8
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
